Description
PF-03758309isanATP-competitiveinhibitorofp21-activatedkinase4(PAK4),akinasetypicallyupregulatedinmanycancers.Thiscompoundexhibitsanticancerchemotherapeuticandanti-metastaticactivities.InhibitionofPAK4inhibitscellmotility,proliferation,andsurvivalincellularmodelsofcancerandsuppressestumorgrowthinanimalmodelsofcancer.PF-03758309alsoinhibitsfusionandmigrationofpreosteoclasts,osteoclastdifferentiation,andpodosomeformationincellularmodelsofosteoclast-relateddisorders.
References
ChoiSW,YeonJT,RyuBJ,etal.RepositioningPotentialofPAK4toOsteoclasticBoneResorption.JBoneMinerRes.2015Jan31.[Epubaheadofprint].PMID:25640698.
RyuBJ,LeeH,KimSH,etal.PF-3758309,p21-activatedkinase4inhibitor,suppressesmigrationandinvasionofA549humanlungcancercellsviaregulationofCREB,NF-κB,andβ-cateninsignalingsMolCellBiochem.2014Apr;389(1-2):69-77.PMID:24366569.
MurrayBW,GuoC,PirainoJ,etal.Small-moleculep21-activatedkinaseinhibitorPF-3758309isapotentinhibitorofoncogenicsignalingandtumorgrowth.ProcNatlAcadSciUSA.2010May18;107(20):9446-51.PMID:20439741.
www.clinicaltrials.gov/show/NCT00932126